Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−23 JPY
−1.13 B JPY
316.82 M JPY
14.03 M
About NOILE-IMMUNE BIOTECH INC
Sector
Headquarters
Tokyo
Founded
2015
Website
ISIN
JP3759560000
FIGI
BBG01FKBX2N2
Noile-Immune Biotech, Inc. is a biotech company. It engages in the development of CAR-T cell therapy, a cancer immunotherapy for solid tumors using proprietary technology. The company was founded on April 16, 2015 and is headquartered in Tokyo, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4893 is 164 JPY — it has increased by 0.61% in the past 24 hours. Watch NOILE-IMMUNE BIOTECH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange NOILE-IMMUNE BIOTECH INC stocks are traded under the ticker 4893.
4893 stock hasn't changed in a week, the month change is a −11.35% fall, over the last year NOILE-IMMUNE BIOTECH INC has showed a −62.21% decrease.
We've gathered analysts' opinions on NOILE-IMMUNE BIOTECH INC future price: according to them, 4893 price has a max estimate of 440.00 JPY and a min estimate of 440.00 JPY. Watch 4893 chart and read a more detailed NOILE-IMMUNE BIOTECH INC stock forecast: see what analysts think of NOILE-IMMUNE BIOTECH INC and suggest that you do with its stocks.
4893 reached its all-time high on Jun 28, 2023 with the price of 775 JPY, and its all-time low was 121 JPY and was reached on May 30, 2024. View more price dynamics on 4893 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4893 stock is 2.47% volatile and has beta coefficient of 1.81. Track NOILE-IMMUNE BIOTECH INC stock price on the chart and check out the list of the most volatile stocks — is NOILE-IMMUNE BIOTECH INC there?
Today NOILE-IMMUNE BIOTECH INC has the market capitalization of 7.10 B, it has increased by 6.92% over the last week.
Yes, you can track NOILE-IMMUNE BIOTECH INC financials in yearly and quarterly reports right on TradingView.
NOILE-IMMUNE BIOTECH INC is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
4893 net income for the last quarter is −343.24 M JPY, while the quarter before that showed −340.18 M JPY of net income which accounts for −0.90% change. Track more NOILE-IMMUNE BIOTECH INC financial stats to get the full picture.
No, 4893 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 28.00 employees. See our rating of the largest employees — is NOILE-IMMUNE BIOTECH INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOILE-IMMUNE BIOTECH INC EBITDA is −975.71 M JPY, and current EBITDA margin is −244.74%. See more stats in NOILE-IMMUNE BIOTECH INC financial statements.
Like other stocks, 4893 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOILE-IMMUNE BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOILE-IMMUNE BIOTECH INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOILE-IMMUNE BIOTECH INC stock shows the sell signal. See more of NOILE-IMMUNE BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.